Author Jacek Szechiński
ORIGINAL PAPER
Serum IgG galactosylation in psoriatic arthritis patients undergoing a biological treatment. A preliminary report
Anna Jakubiak-Augustyn, Renata Sokolik, Maria Duk, Jacek Szechiński, Piotr Wiland, Elwira Lisowska, Maciej Sobczyński, Hubert Krotkiewski
Reumatologia 2014;52(6):369–376
The use of positron emission therapy (PET) in the diagnosis of large vessel vasculitis – a review of the current research
Reumatologia 2005;43(1):26–30
CASE REPORT
Radiological changes in primary hypertrophic osteoarthropathy: case report
Reumatologia 2005;43(5):293–296
ORIGINAL PAPER
A 6-month trial assessing the safety and efficacy of cyclosporine treatment in patients with active rheumatoid arthritis
Reumatologia 2005;43(5):257–264
The safety and efficacy of adalimumab for the treatment of ankylosing spondylitis (AS) and active psoriatic arthritis (PsA) in patients in a 16-week study
Reumatologia 2007;45(5):248–257
Orginal paper
Efficacy and safety of adalimumab in treatment of patients with rheumatoid arthritis
Reumatologia 2007;45(5):241–247
REVIEW PAPER
Adalimumab – the first fully human monoclonal antibody used in the treatment of rheumatoid arthritis
Jacek Szechiński, Sławomir Jeka, Krzysztof Borysewicz, Anna Filipowicz-Sosnowska, Katarzyna Kolossa, Eugeniusz J. Kucharz, Beata Nowak, Jerzy Świerkot, Piotr Wiland
Reumatologia 2008;46(3):151–158
ORIGINAL PAPER
A cross-sectional survey of treatment patterns, disease activity, and quality of life of patients with ankylosing spondylitis in Central and Eastern Europe
Jacek Szechiński, Wolfgang Ebner, Tamás Palotai, Catalin Codrenu, Pál Géher, Artur Pahor, Karel Pavelka, Josef Smolen, Martin Žlany
Reumatologia 2008;46(3):130–139
STANDARDS OF TREATMENT
Position of the Expert Panel of the National Consultant for Rheumatology concerning diagnosis and treatment of rheumatoid arthritis
Witold Tłustochowicz, Marek Brzosko, Anna Filipowicz-Sosnowska, Piotr Głuszko, Eugeniusz J. Kucharz, Włodzimierz Maśliński, Włodzimierz Samborski, Jacek Szechiński, Piotr Wiland
Reumatologia 2008;46(3):111–114
Standard sof treatment
The Expert Panel of the National Consultant for Rheumatology recommendations for the management of ankylosing spondylitis
Piotr Wiland, Anna Filipowicz-Sosnowska, Piotr Głuszko, Eugeniusz J. Kucharz, Włodzimierz Maśliński, Włodzimierz Samborski, Jacek Szechiński, Witold Tłustochowicz, Marek Brzosko
Reumatologia 2008;46(4):191–197
Original paper
Clinical efficacy and safety of oral versus subcutaneous administration of methotrexate in patients with rheumatoid arthritis
Jerzy Świerkot, Renata Sokolik, Katarzyna Gruszecka-Marczyńska, Ryszard Międzybrodzki, Jacek Szechiński
Reumatologia 2008;46(6):322–329
ORIGINAL PAPER
Effect of methylenetetrahydrofolate reductase polymorphism on toxicity and efficacy of methotrexate in patients with rheumatoid arthritis
Jerzy Świerkot, Ryszard Ślęzak, Paweł Karpiński, Justyna Pawłowska, Leszek Noga, Jacek Szechiński, Piotr Wiland
Reumatologia 2010;48(2):81–93
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.